(Q48786342)

English

Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy.

scientific article published in September 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

Parkinson's disease

1 reference

based on heuristic

inferred from title

substantia nigra

1 reference

based on heuristic

inferred from title

1 reference

ORCID Public Data File 2021

author name string

Berg D

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

Jabs B

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

Merschdorf U

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

Beckmann H

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

Becker G

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

50

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

463-467

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Iron accumulation in the substantia nigra in rats visualized by ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Neuroleptic-induced parkinsonism in older schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Extrapyramidal effects of neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Reversible drug-induced parkinsonism. Clinicopathologic study of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Iron induces degeneration of nigrostriatal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathophysiology of extrapyramidal side-effects of neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901190-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-3223(01)01190-8

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/11566164

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48786342&oldid=1614822523"